Successful dupilumab therapy for atopic dermatitis in a patient with X-linked agammaglobulinaemia

Detalles Bibliográficos
Autores principales: Fujishima, Chieko, Munemoto, Sawa, Hioki, Chika, Sasaki, Hiroka, Yoshida, Haruka, Yamamoto, Tetsuro, Kudo, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Libbey Eurotext 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660116/
https://www.ncbi.nlm.nih.gov/pubmed/36065552
http://dx.doi.org/10.1684/ejd.2022.4288
_version_ 1784830354333368320
author Fujishima, Chieko
Munemoto, Sawa
Hioki, Chika
Sasaki, Hiroka
Yoshida, Haruka
Yamamoto, Tetsuro
Kudo, Hitoshi
author_facet Fujishima, Chieko
Munemoto, Sawa
Hioki, Chika
Sasaki, Hiroka
Yoshida, Haruka
Yamamoto, Tetsuro
Kudo, Hitoshi
author_sort Fujishima, Chieko
collection PubMed
description
format Online
Article
Text
id pubmed-9660116
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Libbey Eurotext
record_format MEDLINE/PubMed
spelling pubmed-96601162022-11-14 Successful dupilumab therapy for atopic dermatitis in a patient with X-linked agammaglobulinaemia Fujishima, Chieko Munemoto, Sawa Hioki, Chika Sasaki, Hiroka Yoshida, Haruka Yamamoto, Tetsuro Kudo, Hitoshi Eur J Dermatol Correspondence John Libbey Eurotext 2022-11-12 2022 /pmc/articles/PMC9660116/ /pubmed/36065552 http://dx.doi.org/10.1684/ejd.2022.4288 Text en © JLE/Springer 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Correspondence
Fujishima, Chieko
Munemoto, Sawa
Hioki, Chika
Sasaki, Hiroka
Yoshida, Haruka
Yamamoto, Tetsuro
Kudo, Hitoshi
Successful dupilumab therapy for atopic dermatitis in a patient with X-linked agammaglobulinaemia
title Successful dupilumab therapy for atopic dermatitis in a patient with X-linked agammaglobulinaemia
title_full Successful dupilumab therapy for atopic dermatitis in a patient with X-linked agammaglobulinaemia
title_fullStr Successful dupilumab therapy for atopic dermatitis in a patient with X-linked agammaglobulinaemia
title_full_unstemmed Successful dupilumab therapy for atopic dermatitis in a patient with X-linked agammaglobulinaemia
title_short Successful dupilumab therapy for atopic dermatitis in a patient with X-linked agammaglobulinaemia
title_sort successful dupilumab therapy for atopic dermatitis in a patient with x-linked agammaglobulinaemia
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660116/
https://www.ncbi.nlm.nih.gov/pubmed/36065552
http://dx.doi.org/10.1684/ejd.2022.4288
work_keys_str_mv AT fujishimachieko successfuldupilumabtherapyforatopicdermatitisinapatientwithxlinkedagammaglobulinaemia
AT munemotosawa successfuldupilumabtherapyforatopicdermatitisinapatientwithxlinkedagammaglobulinaemia
AT hiokichika successfuldupilumabtherapyforatopicdermatitisinapatientwithxlinkedagammaglobulinaemia
AT sasakihiroka successfuldupilumabtherapyforatopicdermatitisinapatientwithxlinkedagammaglobulinaemia
AT yoshidaharuka successfuldupilumabtherapyforatopicdermatitisinapatientwithxlinkedagammaglobulinaemia
AT yamamototetsuro successfuldupilumabtherapyforatopicdermatitisinapatientwithxlinkedagammaglobulinaemia
AT kudohitoshi successfuldupilumabtherapyforatopicdermatitisinapatientwithxlinkedagammaglobulinaemia

Ejemplares similares